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1. Introduction 
Previous studies [ 1,2] on the action of gluco- 
corticoids in lymphoid tissues have shown that various 
catabolic effects interfere with RNA synthesis either 
directly or indirectly. A decrease in DNA-dependent 
RNA polymerase (nucleoside triphosphate-RNA 
nucleotidyltransferase: EC 2.7.7.6) activity in rat 
thymus cells has been demonstrated in vivo 3 h after 
the administration of cortisol [3,4]. Although several 
studies have implicated an early stimulation of RNA 
in response to the hormone by indirect evidence such 
as the use of inhibitors of RNA and protein synthesis 
[S-7], no direct evidence has previously been obtain- 
ed. This paper describes an early glucocorticoid- 
dependent increase in RNA polymerase B activity in 
rat thymus cells within 10 min of steroid administra- 
tion in vitro. 
2. Experimental 
2.1. Materials 
[5-3 H] UTP (1 Ci/mmol) was purchased from the 
Radiochemical Centre, Amersham, Bucks, UK, ATP, 
CTP, GTP and UTP were supplied by Boehringer 
(Mannheim, West Germany), cr-amanitin was obtained 
from Calbiochem Ltd., London, and dexamethasone 
(9a-fluoro-l6cY-methyl-110, 17, 21_trihydroxypregna- 
1,4-diene-3,20-dione) was the product of Sigma 
(London) Chem. Co. Ltd. Minimal Essential Medium 
(Eagle): (MEM) was supplied by Gibco Bio-Cult 
(Paisley, Scotland). 
2.2. kicperimental animals 
Male Sprague-Dawley rats weighing 250-3.50 g at 
age of 7-S weeks were adrenalectomised 1 week before 
use. In in vivo experiments, animals were injected under 
ether anaesthesia via the jugular vein with dexametha- 
sone (10 yg/ 100 g body wt) in 0.9% saline. Control 
animals received vehicle alone. 
2.3. Preparation of thymus cell suspension 
The animals were killed by decapitation, the thymi 
removed and washed in ice-cold 0.9% NaCl. The tissue 
was minced and hand-homogenised in a Teflon-glass 
homogeniser (1 mm clearance) in 20 ml MEM. The 
homogenate was filtered through 4 layers of muslin 
and centrifuged for 2 min at 600 g. After removal of 
supernatant, the pellet was resuspended in MEM and 
recentrifuged for 2 min at 600 g. The final pellet was 
then suspended in MEM, with a final cell concentra- 
tion of 335%. 
2.4. In vitro incubations 
Cell suspensions were incubated at 37°C in a shaking 
water bath under an atmosphere of 95% O2 15% CO2 . 
Dexamethasone was added to a final concentration of 
IOe6 M; control incubations received saline alone. 
2.5. Preparation of nuclei from cell suspensions 
Nuclei were isolated from thymus cell suspensions 
by the hypo-osmotic shock technique [8]. The suspen- 
sion was centrifuged for 15 min at 800 g and the crude 
nuclear pellet was resuspended in 0.32 M sucrose. 
Purified nuclei were prepared by the method of 
Blobel and Potter [9]. 
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2.6. RNA polymerase assay 
RNA polymerase activity was assayed in isolated 
nuclei in either low salt t cy-amanitin to measure RNA 
polymerase A activity or high salt to measure RNA 
polymerase B activity. The reaction mixture contained 
in a final volume of 0.08 ml (including 0.05 ml 
nuclear suspension) 0.075 pmol each of ATP, CTP and 
GTP, 0.005 pmol of [“HI UTP (0.5 &i), 0.8 pmol 
TrissHCl, pH 8, 0.2 pmol of 2-mercaptoethanol and 
5% (v/v) glycerol. Under low-salt conditions, the mix- 
ture also contained 0.24 pmol MgCl*, 4 pm01 of KC1 
and 0.1 1-16 of oc-amanitin. Assays carried out in high- 
salt conditions contained 0.32 pmol MnCl* and 16 
pmol of (NH4),S04. Assays were started by the addi- 
tion of 0.05 ml of nuclear suspension to reaction mix- 
ture and incubation carried out at 37°C for 15 min. 
Samples of the reaction mixture were used to determine 
enzyme activity as described previously [lo] . 
Radioactivity was measured in a Nuclear Chicago 
Mark II liquid scintillation spectrometer with tritium 
counting efficiency of 28-32%. 
DNA determinations were carried out by the 
method of Burton [ 111. 
3. Results 
3.1. Effect of dexamethasone on RNA polymerase 
activity in vivo 
Most previous work [3,4] on the inhibition of RNA 
polymerase by cortisol in vivo was carried out with a 
minimum time of 3 h between hormone administration 
and enzyme assay. In the present experiments, both RNA 
polymerase A and B activities have been measured from 
30 min to 3 h after a single i.v. injection of dexametha- 
sone. Fig. 1 a shows the activity of RNA polymerase A in 
isolated thymus nuclei. From 30 min to 1 h after 
hormone administration, the enzyme activity remains 
similar to that in control animals but thereafter 
decreases to about 70% of control values by 3 h. A 
similar pattern is obtained with RNA polymerase B 
activity (fig.lb). Again, the enzyme activity remains 
at control values from 30 min to 1 h and then decreases 
to 70-75% of control values 3 h after dexamethasone 
treatment. Since it is not possible to examine time 
intervals much shorter than 30 min in vivo, further 
studies were carried out using suspension of thymus 
cells in vitro. 
3.2. Effect of dexamethasone on RNA polymerase 
activity in vitro 
Incubation of thymus cell suspensions with low6 M 
dexamethasone in vitro facilitates the measurement of 
RNA polymerase activities in thymus nuclei at much 
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Fig.1. Effect of dexamethasone in vivo on RNA polymerase 
activities in rat thymus. Rats were treated with dexamethasone 
for periods up to 3 h and nuclei were prepared from thymi and 
assayed for RNA polymerasc activity as described in the 
Experimental section. Each point represents the mean + SD. 
obtained from at least six determinations.(a) RNA polymerase 
A activity in dexamcthasone-treated (0) and control (0) thymi. 
(b) RNA polymerase B activity in desamethasone-treated 
(0) and control (0) thymi. 
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earlier time intervals. RNA polymerase A activity 
(fig.2a) is identical to the obtained in vivo after 
hormone treatment although the degree of variation 
is considerably reduced. Tl1e decrease in enzyme 
activity is evident from 1 h and reaches 30% by 3 h. 
However steroid treatment produces a striking effect 
14 
0) 
1 
Y 
0-0 
TIME OF INCUBATION WITH DEXAMETHASONE (min) 
I:ig.2. Effect of dexamethasone in vitro on RNA polymerase 
activities in rat thymus cells. Thymus cell suspensions were 
incubated with 10m6 M dexamethasone for periods up to 3 h 
and nuclei were prepared and assayed for RNA polymerase 
activity as described in the Experimental section. Each point 
represents the mean * SD. obtained from six determinations. 
(a) RNA polymerase A activity in dexamethasone-treated (0) 
and control (0) thymus cells. (b) RNA polymerase B activity 
in dexamethasone-treated (0) and control (o) thymus cells. 
on RNA polymerase B activity in vitro previously 
undetected in the in vivo experiments (fig.2b). It is 
apparent that there is a rapid burst of RNA poly- 
merase B activity 10 min after hormone addition. This 
activity reaches a maximum at 15-20 min at about 
15520% above the corresponding control values 
before declining to control levels by 30-40 nun with 
the subsequent inhibition of activity after 1 I1 as 
already shown in the in vivo experiments. 
4. Discussion 
The majority of metabolic effects of glucocorticoids 
on thymic lymphocytes have been shown to be blocked 
or counteracted by inhibitors of RNA synthesis such as 
actinomycin D or cordycepin. Examples are the inhibi- 
tion of the decrease in generation of glucose 6-phos- 
phate from glucose [5,7] and of the decrease in hexose 
transport [ 121 . Tl1e period of sensitivity to RNA 
synthesis inhibitors generally precedes the sensitivity 
to inhibitors of protein synthesis such as cycloheximide. 
In thymic lymphocytes the inhibitory effects of 
glucocorticoids on glucose metabolism, which occur 
15 min after hormone administration, are blocked 
only if the inhibitors are present during the first 
S-10 min after exposure to hormone. These experi- 
ments imply the involvement of an early stimulation 
in RNA synthesis as an early effect of glucocorticoids 
on target tissue. In this paper, we have demonstrated 
that such an early stimulation in RNA synthesis does 
occur in vitro (fig.2). The enhancement of RNA poly- 
merase B activity in isolated tl1yn1ic nuclei by 15%20%, 
10-l 5 min after dexamethasone treatment, is the 
first direct demonstration of the involvement of RNA 
synthesis in the primary action of this hormone. It is 
probable that the increase in enzyme activity observed 
in isolated nuclei is a consequence of changes in the 
thymic chromatin, arising directly from the interac- 
tion of dexamethasone and its receptor protein with 
specific sites in the chromatin. RNA polymerase B is 
believed to synthesise high molecular weight nuclear 
RNA which may be the precursor for mRNA [ 131. 
The increased level of mRNA could result either from 
an increase in the rate of transcription or a decrease 
in the rate of degradation; this problem is now under 
study. 
It is believed that some of the inhibitory and 
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catabolic effects of glucocorticoids are mediated by 
a decrease in glucose uptake, which leads to decreased 
incorporation of precursors into RNA and lower ATP 
levels, although substrates other than glucose can 
function in its place [ 141. The paths of glucocorticoid 
action may separate early in the response, perhaps 
through the induction of several different proteins, 
one of which inhibits glucose uptake and another which 
initiates the mechanisms resulting in cell death. 
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